Opioid Settlement Impact on PI Pharmacy Practice: What Attorneys Should Know

James Wong — Founder & CEO, LienScripts | March 4, 2026 | 7 min read

National opioid settlements are reshaping how pharmacies dispense controlled substances, affecting pain management for PI patients. LienScripts pharmacy lien services navigate post-settlement prescribing restrictions while ensuring patients receive appropriate pain medications.

National opioid settlements with pharmaceutical manufacturers, distributors, and pharmacy chains have resulted in billions of dollars in payments and, more importantly for personal injury practice, significant changes to how opioid medications are prescribed, dispensed, and monitored. These post-settlement changes affect every personal injury patient who requires opioid pain management, creating new barriers to medication access that did not exist before the settlements. Pharmacy lien services through LienScripts navigate these post-settlement requirements while ensuring that personal injury patients receive clinically appropriate pain management medications without unnecessary delays.

• National opioid settlements have imposed new prescribing and dispensing restrictions on pharmacies and prescribers
• Post-settlement monitoring programs flag high-volume prescribers and pharmacies, sometimes affecting legitimate injury patients
• Personal injury patients requiring opioid pain management face increased scrutiny and access barriers
• LienScripts pharmacy lien services work within post-settlement frameworks to ensure appropriate pain medication access
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages

How Opioid Settlements Changed Pharmacy Practice

The multi-billion-dollar opioid settlements resolved claims against manufacturers, distributors, and pharmacies accused of contributing to the opioid crisis. Beyond the financial payments, the settlements imposed operational changes:

Enhanced prescription monitoring. Pharmacies are required to flag and investigate suspicious prescribing patterns, including high-dose prescriptions, early refills, and prescriptions from multiple providers.

Dispensing limits. Some settlement terms include protocols for pharmacies to decline to fill opioid prescriptions that exceed certain dose thresholds without additional clinical documentation.

Prescriber education requirements. Settlement terms may require continuing education for prescribers on responsible opioid prescribing practices, potentially making prescribers more conservative in their opioid prescribing.

Prescription drug monitoring program (PDMP) participation. Enhanced PDMP requirements mandate that prescribers and pharmacists check the state monitoring database before prescribing or dispensing opioids, adding a step to the dispensing process.

According to James Wong, PharmD, founder of LienScripts, "The opioid settlements were necessary to address a public health crisis. But the resulting restrictions create real problems for legitimate injury patients who need opioid pain management. The challenge is ensuring that post-settlement safeguards do not become barriers to appropriate care for someone who just had a car accident."

Impact on Personal Injury Patients

Pharmacy Refusal to Fill

Post-settlement, pharmacies are more cautious about filling opioid prescriptions. Pharmacists who perceive a prescription as outside normal parameters may decline to fill it, even when the prescription is clinically appropriate for an acute injury. Personal injury patients with legitimate prescriptions from treating physicians sometimes find themselves turned away at the pharmacy counter.

Prescriber Conservatism

Prescribers aware of post-settlement scrutiny may be more conservative in their opioid prescribing. This can result in undertreated pain for personal injury patients, lower opioid doses than clinically indicated, or pressure to rely on non-opioid alternatives that may not adequately manage severe injury pain.

PDMP Delays

While PDMP checks are important safety measures, they add time to the dispensing process. For personal injury patients filling prescriptions at pharmacies that are not familiar with their case, the PDMP check may trigger questions or delays if the patient has received opioid prescriptions from multiple providers during their injury treatment.

Monitoring Program Flags

Enhanced monitoring programs may flag personal injury patients who receive opioids from multiple prescribers during their treatment, such as an emergency department physician, an orthopedic surgeon, and a pain management specialist. These flags can create dispensing delays even though multiple-prescriber patterns are normal for complex injury cases.

How LienScripts Navigates Post-Settlement Requirements

The LienScripts pharmacy lien model addresses post-settlement opioid challenges through several mechanisms:

Clinical Context for Dispensing

When a personal injury patient's opioid prescription is filled through the LienScripts network, the dispensing pharmacy has context about the patient's case. The pharmacist understands that the patient is being treated for a traumatic injury and that the opioid prescription is part of a documented treatment plan. This clinical context reduces the likelihood of inappropriate refusal to fill.

Pharmacist-Prescriber Communication

LienScripts pharmacists communicate directly with prescribers when questions arise about opioid prescriptions. Rather than declining to fill and sending the patient back to the prescriber, the pharmacist resolves clinical questions in real time.

Documentation Trail

The MERIT report from LienScripts documents every opioid dispensing in the context of the complete medication timeline. This documentation shows the clinical progression from injury through treatment, demonstrating that opioid use was appropriate, time-limited, and part of a comprehensive treatment plan. For demand package preparation, this documentation is essential.

Compliance with All Requirements

LienScripts network pharmacies comply with all post-settlement PDMP requirements, dispensing protocols, and monitoring obligations. The pharmacy lien does not circumvent safety measures; it ensures that safety measures are applied with appropriate clinical context.

Defense Opportunities and Challenges

Opioid Use as a Defense Target

Defense counsel may attempt to characterize opioid use as excessive, unnecessary, or indicative of pre-existing dependence. The detailed documentation in the MERIT report counters these arguments by showing the clinical rationale, dosing progression, and treatment timeline for opioid medications.

Settlement Context

Attorneys should be aware that opioid settlement-related changes may appear in the medical record as prescriber notes about opioid prescribing guidelines. These notes reflect systemic changes, not specific concerns about the individual patient. For information on opioid management in PI cases, the clinical context guide provides additional detail.

Practical Guidance

Attorneys handling cases where opioid pain management is prescribed should connect clients with LienScripts early. Post-settlement pharmacy environments make opioid access unpredictable through standard insurance channels. The pharmacy lien provides a structured, documented pathway for opioid dispensing that works within post-settlement requirements while ensuring patients receive appropriate pain management.

The goal is not to increase opioid prescribing but to ensure that when a prescriber determines an opioid is medically necessary for an injury, the patient can actually obtain it without navigating a maze of post-settlement restrictions on their own.